8-K
filed June 9, 2026, 6:02 AM ET
ticker CRVO
CIK 0001053691
other material
confidence high
sentiment neutral
materiality 0.15
CervoMed stockholders approve all four proposals at 2026 annual meeting
CervoMed Inc.
- Elected eight directors with 3.1M+ votes for each; broker non-votes of ~3.0M on each.
- Ratified RSM US LLP as auditor for FY 2026: 6,092,751 for, 21,433 against.
- Approved advisory say-on-pay for named executive officers: 3,073,013 for, 104,221 against.
- Approved Amendment No. 1 to 2025 Equity Incentive Plan: 3,044,744 for, 132,860 against.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CervoMed Inc. shareholders approved Election of eight directors at the 2026-06-08 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-08
Exact text from the filing
The election of each nominee pursuant to Proposal No. 1 required the affirmative vote of a plurality of the votes present and entitled to vote at the Annual Meeting and, accordingly, each nominee received the requisite number of votes for election at the Annual Meeting.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CervoMed Inc. shareholders approved Ratification of RSM US LLP as independent registered public accounting firm for 2026 at the 2026-06-08 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-08
Exact text from the filing
To ratify the selection of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CervoMed Inc. shareholders approved Amendment No. 1 to the 2025 Equity Incentive Plan at the 2026-06-08 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-06-08
Exact text from the filing
To approve Amendment No. 1 to the CervoMed Inc. 2025 Equity Incentive Plan.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CervoMed Inc. shareholders approved Advisory approval of executive compensation for fiscal year 2024 at the 2026-06-08 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-08
Exact text from the filing
To approve, on an advisory basis, the compensation of the Company’s named executive officers during the year ended December 31, 2024, as disclosed in the Proxy Statement.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.